Increased rate of glutathione synthesis from cystine in drug-resistant MCF-7 cells

被引:26
|
作者
Gamcsik, MP
Dubay, GR
Cox, BR
机构
[1] Duke Univ, Med Ctr, Duke Comprehens Canc Ctr, Dept Med, Durham, NC 27710 USA
[2] Duke Univ, Dept Chem, Durham, NC 27710 USA
关键词
glutathione; biosynthesis; drug resistance; breast cancer; stable isotope; metabolism;
D O I
10.1016/S0006-2952(01)00931-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The rate of glutathione synthesis was determined in drug-sensitive and -resistant MCF-7 cells by monitoring the rate of label uptake from [3,3'-C-13(2)]-cystine using NMR spectroscopy and mass spectrometry. Compared with the wild-type human mammary adenocarcinoma cell line (MCF-7wt), the isotope incorporation rate was increased 1.6-, 2.4-, and 5.3-fold in the etoposide-resistant MCF-7 cell line (MCF-7vp), doxorubicin-resistant MCF-7 cell line (MCF-7adr), and 4-hydroperoxycyclophosphamide-resistant MCF-7 cell line (MCF-7hc), respectively. The increase in glutathione metabolism in the MCF-7hc line correlated with steady-state levels as determined by biochemical assay. In contrast, both the MCF-7vp and MCF-7adr lines showed increased metabolic synthesis of glutathione but displayed lower steady-state levels compared with the MCF-7wt line. The increased synthetic rates of all resistant lines reflected, in part. contributions from the increased activities of both gamma-glutamyltranspeptidase and gamma-glutamylcysteine synthetase. These results emphasize the importance of monitoring glutathione metabolic rates, rather than steady-state levels of enzymes or substrates, for assessing drug resistance. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:843 / 851
页数:9
相关论文
共 50 条
  • [1] Drug-resistant breast carcinoma (MCF-7) cells are paradoxically sensitive to apoptosis
    Chen, JSK
    Konopleva, M
    Andreeff, M
    Multani, AS
    Pathak, S
    Mehta, K
    JOURNAL OF CELLULAR PHYSIOLOGY, 2004, 200 (02) : 223 - 234
  • [2] Berberine enhances the anti-tumor activity of tamoxifen in drug-sensitive MCF-7 and drug-resistant MCF-7/TAM cells
    Wen, Chunjie
    Wu, Lanxiang
    Fu, Lijuan
    Zhang, Xue
    Zhou, Honghao
    MOLECULAR MEDICINE REPORTS, 2016, 14 (03) : 2250 - 2256
  • [3] Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells
    Herman, J. F.
    Mangala, L. S.
    Mehta, K.
    ONCOGENE, 2006, 25 (21) : 3049 - 3058
  • [4] Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells
    J F Herman
    L S Mangala
    K Mehta
    Oncogene, 2006, 25 : 3049 - 3058
  • [5] Reversal of Multidrug Resistance by Guggulsterone in Drug-Resistant MCF-7 Cell Lines
    Xu, Hong-Bin
    Li, Ling
    Liu, Guo-Qing
    CHEMOTHERAPY, 2011, 57 (01) : 62 - 70
  • [6] Increased glutathione metabolism in drug-resistant breast cancer cells
    Gamcsik, MP
    Dubay, GR
    Cox, BR
    FREE RADICAL BIOLOGY AND MEDICINE, 2001, 31 : S138 - S138
  • [7] Gene expression analysis of drug-resistant MCF-7 cells: implications for relation to extracellular matrix proteins
    Özlem Darcansoy Işeri
    Meltem Demirel Kars
    Fikret Arpaci
    Ufuk Gündüz
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 447 - 455
  • [8] Gene expression analysis of drug-resistant MCF-7 cells: implications for relation to extracellular matrix proteins
    Iseri, Oezlem Darcansoy
    Kars, Meltem Demirel
    Arpaci, Fikret
    Gunduz, Ufuk
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (03) : 447 - 455
  • [9] Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common monoclonal drug-resistant progenitor
    Coser, Kathryn R.
    Wittner, Ben S.
    Rosenthal, Noel F.
    Collins, Sabrina C.
    Melas, Antonia
    Smith, Shannon L.
    Mahoney, Crystal J.
    Shioda, Keiko
    Isselbacher, Kurt J.
    Ramaswamy, Sridhar
    Shioda, Toshi
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (34) : 14536 - 14541
  • [10] Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells
    Phillip J. Daschner
    Henry P. Ciolino
    Cathie A. Plouzek
    Grace Chao Yeh
    Breast Cancer Research and Treatment, 1999, 53 : 229 - 240